The role of oxidative stress in the development of both schizophrenia and affective diseases has been described (Lindqvist et al., 2017), which is another argument confirming that MMP-9 is important in the pathogenesis of these diseases and GEMIN genes through MMP9 and inflammation that is possibly associated with depression. This evidence concerns the gene MMP9 and depressive symptom measurement.